Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Liquidia Corp
(NQ:
LQDA
)
12.79
-0.19 (-1.46%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Liquidia Corp
< Previous
1
2
Next >
Liquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare Conference
April 02, 2024
From
Liquidia Corporation
Via
GlobeNewswire
Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA™ (treprostinil) inhalation powder
April 01, 2024
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Corporation Reports Full Year 2023 Financial Results and Provides Corporate Update
March 13, 2024
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Corp. (NASDAQ: LQDA) Leading the Way in Wednesday Trading Based on Percentage Gain
December 20, 2023
Via
Investor Brand Network
Liquidia Corporation to Report Full Year 2023 Financial Results on Wednesday, March 13, 2024
March 06, 2024
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Corporation Announces Poster Presentation at the Pulmonary Vascular Research Institute 2024 Annual Congress
January 30, 2024
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Corporation Provides Update on New Drug Application for YUTREPIA™ (treprostinil) inhalation powder
January 25, 2024
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Corporation Announces Updates to Operations Leadership
January 19, 2024
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Corporation Files Response to United Therapeutics Lawsuit and Files Counterclaims
January 08, 2024
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Provides Update on Clinical Pipeline Targeting PAH and PH-ILD
January 05, 2024
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Corporation Announces $100 Million in New Financings
January 04, 2024
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference
January 02, 2024
From
Liquidia Corporation
Via
GlobeNewswire
MarketBeat Week in Review: 12/25 - 12/29
December 30, 2023
The Santa Claus rally took the S&P 500 up about 0.75%, but recession concerns linger as the full impact of the Fed's rate hikes hasn't hit the economy.
Via
MarketBeat
Topics
Economy
Stocks
Exposures
Economy
Interest Rates
US Equities
Liquidia: Court victory the awakening of an industry giant?
December 27, 2023
Liquidia's stock surged after an enormous court win against United Therapeutics, accompanied by analyst upgrades and insider buying.
Via
MarketBeat
Topics
Intellectual Property
Exposures
Intellectual Property
U.S. Federal Circuit Affirms Earlier PTAB Decision to Invalidate All Claims of United Therapeutics Patent No. 10,716,793 (‘793 Patent)
December 20, 2023
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Announces Pricing of Public Offering of Common Stock
December 12, 2023
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Corporation Reports Third Quarter 2023 Financial Results and Provides Corporate Update
November 07, 2023
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Corporation to Report Third Quarter 2023 Financial Results on November 7, 2023
October 31, 2023
From
Liquidia Corporation
Via
GlobeNewswire
Emergent BioSolutions Names Two Pharmaceutical Industry Veterans to Board of Directors
October 02, 2023
From
Emergent BioSolutions
Via
GlobeNewswire
FDA Accepts Submission to Add PH-ILD to YUTREPIA™ Label
September 25, 2023
From
Liquidia Corporation
Via
GlobeNewswire
United Therapeutics Corporation Files Lawsuit Alleging Infringement of Tyvaso Patent Already Found to Be Invalid by U.S. Patent Office
September 06, 2023
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Corporation Reports Second Quarter 2023 Financial Results and Provides Corporate Update
August 10, 2023
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Corporation to Report Second Quarter 2023 Financial Results on August 10, 2023
August 03, 2023
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Submits Amendment to Add PH-ILD Indication to Tentatively Approved NDA for YUTREPIA™ (treprostinil) Inhalation Powder
July 27, 2023
From
Liquidia Corporation
Via
GlobeNewswire
U.S. Federal Circuit Affirms All District Court Rulings in Patent Litigation
July 24, 2023
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Corporation and Pharmosa Biopharm Announce Collaboration for Sustained-Release Inhaled Treprostinil Product in North America
June 28, 2023
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Corporation to Present at the 2023 Jefferies Healthcare Conference
May 31, 2023
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Announces Poster Presentation at the 2023 American Thoracic Society International Conference
May 19, 2023
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Corporation Reports First Quarter 2023 Financial Results and Provides Corporate Update
May 04, 2023
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Corporation to Present at BofA Securities 2023 Health Care Conference
May 02, 2023
From
Liquidia Corporation
Via
GlobeNewswire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.